Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
   J01 ANTIBACTERIALS FOR SYSTEMIC USE
     J01A TETRACYCLINES
     J01B AMPHENICOLS
     J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS
     J01D OTHER BETA-LACTAM ANTIBACTERIALS
       J01DB First-generation cephalosporins [DG:DG01774]
       J01DC Second-generation cephalosporins [DG:DG01775]
       J01DD Third-generation cephalosporins [DG:DG01776]
         J01DD01 Cefotaxime [DG:DG00570]
         J01DD02 Ceftazidime [DG:DG00571]
         J01DD03 Cefsulodin [DG:DG00572]
         J01DD04 Ceftriaxone [DG:DG00573]
           D07659  Ceftriaxone (INN)
           D00924  Ceftriaxone sodium (USP) <JP/US>
         J01DD05 Cefmenoxime [DG:DG00574]
         J01DD06 Latamoxef [DG:DG00575]
         J01DD07 Ceftizoxime [DG:DG00576]
         J01DD08 Cefixime [DG:DG00577]
         J01DD09 Cefodizime [DG:DG00578]
         J01DD10 Cefetamet [DG:DG00579]
         J01DD11 Cefpiramide [DG:DG00580]
         J01DD12 Cefoperazone [DG:DG00581]
         J01DD13 Cefpodoxime [DG:DG00582]
         J01DD14 Ceftibuten [DG:DG00583]
         J01DD15 Cefdinir
         J01DD16 Cefditoren [DG:DG00584]
         J01DD17 Cefcapene [DG:DG00585]
         J01DD51 Cefotaxime and beta-lactamase inhibitor
         J01DD52 Ceftazidime and beta-lactamase inhibitor
         J01DD54 Ceftriaxone, combinations
         J01DD62 Cefoperazone and beta-lactamase inhibitor
         J01DD63 Ceftriaxone and beta-lactamase inhibitor
       J01DE Fourth-generation cephalosporins [DG:DG01777]
       J01DF Monobactams [DG:DG01454]
       J01DH Carbapenems [DG:DG01458]
       J01DI Other cephalosporins and penems
     J01E SULFONAMIDES AND TRIMETHOPRIM
     J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
     J01G AMINOGLYCOSIDE ANTIBACTERIALS [DG:DG01447]
     J01M QUINOLONE ANTIBACTERIALS [DG:DG01550]
     J01R COMBINATIONS OF ANTIBACTERIALS
     J01X OTHER ANTIBACTERIALS
   J02 ANTIMYCOTICS FOR SYSTEMIC USE
   J04 ANTIMYCOBACTERIALS
   J05 ANTIVIRALS FOR SYSTEMIC USE
   J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J07 VACCINES
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: May 23, 2018
According to WHO's ATC 2018

» Japanese version